
### [MONDO:0016234](http://purl.obolibrary.org/obo/MONDO_0016234)
**Label:** rare arteriovenous malformation

**Subclasses:** [MONDO:0015400](http://purl.obolibrary.org/obo/MONDO_0015400) (frontonasal arteriovenous malformation), [MONDO:0015402](http://purl.obolibrary.org/obo/MONDO_0015402) (mandibular arteriovenous malformation), [MONDO:0015401](http://purl.obolibrary.org/obo/MONDO_0015401) (maxillary arteriovenous malformation), [MONDO:0015500](http://purl.obolibrary.org/obo/MONDO_0015500) (facial arteriovenous malformation), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0019972](http://purl.obolibrary.org/obo/MONDO_0019972) (dural sinus malformation), [MONDO:0018892](http://purl.obolibrary.org/obo/MONDO_0018892) (Wyburn-Mason syndrome), [MONDO:0009930](http://purl.obolibrary.org/obo/MONDO_0009930) (pulmonary arteriovenous malformation (disease)), [MONDO:0015196](http://purl.obolibrary.org/obo/MONDO_0015196) (vein of Galen aneurysm), [MONDO:0019196](http://purl.obolibrary.org/obo/MONDO_0019196) (Foix-Alajouanine syndrome), [MONDO:0007154](http://purl.obolibrary.org/obo/MONDO_0007154) (arteriovenous malformations of the brain), [MONDO:0015407](http://purl.obolibrary.org/obo/MONDO_0015407) (Cerebrofacial arteriovenous metameric syndrome type 3), [MONDO:0015406](http://purl.obolibrary.org/obo/MONDO_0015406) (Cerebrofacial arteriovenous metameric syndrome type 1), [MONDO:0015405](http://purl.obolibrary.org/obo/MONDO_0015405) (Cerebrofacial arteriovenous metameric syndrome), 

**Corr. equiv. classes:** [OMIM:265140](http://purl.obolibrary.org/obo/OMIM_265140), [OMIM:108010](http://purl.obolibrary.org/obo/OMIM_108010), [Orphanet:53721](http://www.orpha.net/ORDO/Orphanet_53721), [Orphanet:156230](http://www.orpha.net/ORDO/Orphanet_156230), [Orphanet:53719](http://www.orpha.net/ORDO/Orphanet_53719), [Orphanet:2038](http://www.orpha.net/ORDO/Orphanet_2038), [Orphanet:79093](http://www.orpha.net/ORDO/Orphanet_79093), [Orphanet:141189](http://www.orpha.net/ORDO/Orphanet_141189), [Orphanet:141168](http://www.orpha.net/ORDO/Orphanet_141168), [Orphanet:1053](http://www.orpha.net/ORDO/Orphanet_1053), [Orphanet:46724](http://www.orpha.net/ORDO/Orphanet_46724), [Orphanet:141174](http://www.orpha.net/ORDO/Orphanet_141174), [Orphanet:141199](http://www.orpha.net/ORDO/Orphanet_141199), [Orphanet:97339](http://www.orpha.net/ORDO/Orphanet_97339), [Orphanet:141171](http://www.orpha.net/ORDO/Orphanet_141171), [Orphanet:141194](http://www.orpha.net/ORDO/Orphanet_141194), 

**Class expressions from DL-Learner:**

- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0005293](http://purl.obolibrary.org/obo/HP_0005293) (Venous insufficiency))) 50.30%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0002624](http://purl.obolibrary.org/obo/HP_0002624) (Abnormal venous morphology))) 50.30%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0001635](http://purl.obolibrary.org/obo/HP_0001635) (Congestive heart failure))) 50.30%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0001009](http://purl.obolibrary.org/obo/HP_0001009) (Telangiectasia))) 50.30%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin))) 47.86%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract))) 47.86%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology))) 47.86%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 47.86%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology))) 47.86%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality))) 47.86%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis))) 45.83%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa))) 45.83%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology))) 45.83%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0009145](http://purl.obolibrary.org/obo/HP_0009145) (Abnormal cerebral artery morphology))) 45.83%
- [HP:0004947](http://purl.obolibrary.org/obo/HP_0004947) (Arteriovenous fistula) and (not ([HP:0004930](http://purl.obolibrary.org/obo/HP_0004930) (Abnormality of the pulmonary vasculature))) 45.83%


